Mkts

Dare Bioscience, Inc.

NASDAQ: DARE
$0.65-0.05 (-6.92%)
As of Nov 12, 3:38 PM ET

Key statistics

Day range
0.640.70
52-week range
0.613.78
Today
Open0.69
Previous close0.65
Volume—
Valuation
Market cap12.99M
P/E ratio—
EPS (TTM)-0.79
Income & risk
Dividend / yield—
Beta1.13
Avg volume413.7K
Discussion

DARE News

Stories mentioning DARE from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue152.002.0025.00(63.00)42.0022.00
Cost of Goods Sold242.000.00
Gross Profit(90.00)0.0025.00
Operating Expenses
Research & Development660.00622.001,1751,4292,2973,3352,6824,934
Sales General & Admin2,2492,309
Total Operating Expenses2,9092,1993,6743,8074,6075,3244,7237,382
Operating Income (Loss)(2,999)(1,471)(3,672)(3,828)(4,581)(5,389)(4,681)(7,359)
Interest Income
Interest Expense
Other Expense(1.00)(276.00)109.00(189.00)203.001,844(21.00)(109.00)
Pretax Income
Tax Provision
Net Income (Loss)(3,000)(1,442)(3,563)(4,016)(4,378)(5,507)(4,703)12,911
Earnings Per Share (Basic)(0.21)(0.13)(0.28)(0.45)(0.50)(0.65)(0.55)1.53
Earnings Per Share (Diluted)(0.21)(0.13)(0.28)(0.45)(0.50)(0.65)(0.55)1.52
Weighted Average Shares Outstanding (Basic)14,52311,17912,7558,8718,7598,4978,5348,411
Weighted Average Shares Outstanding (Diluted)14,52311,17912,7558,8718,7598,4978,5348,476

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About DARE

Dare Bioscience, Inc. (NASDAQ: DARE) is a stock listed on the Nasdaq Stock Market under the ticker symbol DARE. It last traded at $0.6500 (Nov 12, 2026, 3:38 PM ET), down 6.9% on the day. That gives Dare Bioscience a market capitalisation of $13.0M.

Over the past 52 weeks DARE has traded between $0.6100 and $3.78.

Revenue for the quarter ended Mar 31, 2026 was $152.0K; a net loss of $3.0M. Revenue was up 508% from $25.0K in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$152.0K-$3.0M-1973.7%
Dec 31, 2025—-$1.4M—
Sep 30, 2025$2.0K-$3.6M-178150.0%
Jun 30, 2025—-$4.0M—

From Dare Bioscience’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…